Moxifloxacin Hydrochloride

USFDA:Moxifloxacin AU:B3 J01MA14(WHO)S01AE07(WHO) AU:S4(Prescription only)US:℞-only 1-Cyclopropyl-7-[(1S,6S)-2,8-diazabicyclo[4.3.0]nonan-8-yl]-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid 151096-09-2Y[yes] 152946 DB00218Y 134802Y U188XYD42P D08237as HCl:D00874 ChEMBL32Y 070017 DTXSID3048491 Interactive image COc1c2c(cc(c1N3C[C@@H]4CCCN[C@@H]4C3)F)c(=O)c(cn2C5CC5)C(=O)O InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1YKey:FABPRXSRWADJSP-MEDUHNTESA-NY Moxifloxacinis anantibiotic, used to treatbacterial infections,includingpneumonia,conjunctivitis,endocarditis,tuberculosis, andsinusitis.It can be given by mouth, byinjection into a vein, and as aneye drop. Common side effects includediarrhea, dizziness, and headache.Severe side effects may include spontaneoustendon ruptures,nerve damage, and worsening ofmyasthenia gravis.Safety of use inpregnancyandbreastfeedingis unclear.Moxifloxacin is in thefluoroquinolonefamily of medications.It usuallykills bacteriaby blocking their ability to duplicateDNA. Moxifloxacin was patented in 1988 and approved for use in the United States in 1999.It is on theWorld Health Organization's List of Essential Medicines.In 2023, it was the 237th most commonly prescribed medication in the United States, with more than one million prescriptions.